APTV · Aptiv PLC · Insider Trading

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $48.54 to $48.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchage Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $50.275 to $50.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchage Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $50.18 to $50.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $48.81 to $48.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2026.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $57.69 to $57.79, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The Reporting Person has received restricted stock units that each represent a right to receive one ordinary share of the Issuer pursuant to the Issuer's Long Term Incentive Plan and will vest in full one day before the Issuer's Annual Meeting of Shareholders in 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Each performance share represents a contingent right to receive an ordinary share of Aptiv PLC, and will vest based upon the achievement of specified performance criteria, with a performance period from January 1, 2026 to December 31, 2028.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

The shares will vest in three equal installments beginning on February 28, 2027.

Total reflects adjustment of outstanding awards as a result of the spin-off of Versigent PLC.

Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2023-2025 performance period.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2023-2025 performance period.

Shares withheld to pay tax liabilities incident to the vesting of restricted stock units.

Additional ordinary shares acquired in connection with achievement in excess of target of specified performance criteria for the 2023-2025 performance period.